Unit Four: Autonomic Nervous System Drugs; This is a 4 week activity. You will stay in your team for each of the weeks that follow. Prepare a 15 minute Summary Presentation for class to include the following: Teams must distill the material to only key points. The presentation may be a Power Point, lecture and handouts, poster or any way the team feels they will best present the information. Use your textbook and as your resources.

Title: Autonomic Nervous System Drugs: Pharmacological Analysis and Therapeutic Applications

Introduction:
The autonomic nervous system (ANS) regulates the involuntary functions of the human body, such as heart rate, blood pressure, digestion, and respiration. Dysfunction of the ANS can contribute to various diseases, necessitating the development of pharmacological interventions to modulate its activity. This presentation will provide an overview of the key points regarding autonomic nervous system drugs, their classification, mechanisms of action, and therapeutic applications.

I. Classification of Autonomic Nervous System Drugs
A. Sympathomimetic Drugs
1. Definition and Mechanism of Action
2. Examples and Clinical Uses
B. Sympatholytic Drugs
1. Definition and Mechanism of Action
2. Examples and Clinical Uses
C. Parasympathomimetic Drugs
1. Definition and Mechanism of Action
2. Examples and Clinical Uses
D. Parasympatholytic Drugs
1. Definition and Mechanism of Action
2. Examples and Clinical Uses

II. Sympathomimetic Drugs
A. Adrenergic Agonists
1. Direct-acting Agonists
a. Epinephrine
b. Norepinephrine
c. Isoproterenol
2. Indirect-acting Agonists
a. Amphetamine
b. Ephedrine
3. Clinical Uses and Adverse Effects
B. Adrenergic Antagonists
1. Alpha-blockers
a. Prazosin
b. Phentolamine
2. Beta-blockers
a. Propranolol
b. Metoprolol
3. Clinical Uses and Adverse Effects

III. Parasympathomimetic Drugs
A. Cholinergic Agonists
1. Direct-acting Agonists
a. Bethanechol
b. Pilocarpine
2. Indirect-acting Agonists
a. Neostigmine
b. Physostigmine
3. Clinical Uses and Adverse Effects
B. Cholinergic Antagonists
1. Muscarinic Antagonists
a. Atropine
b. Scopolamine
2. Ganglionic Blockers
a. Hexamethonium
b. Mecamylamine
3. Clinical Uses and Adverse Effects

IV. Therapeutic Applications of Autonomic Nervous System Drugs
A. Cardiovascular Disorders
1. Hypertension
2. Heart Failure
3. Arrhythmias
B. Respiratory Disorders
1. Asthma
2. Chronic Obstructive Pulmonary Disease (COPD)
C. Gastrointestinal Disorders
1. Peptic Ulcer Disease
2. Gastroesophageal Reflux Disease (GERD)
D. Ophthalmic Disorders
1. Glaucoma
2. Miosis induction for ocular surgery
E. Genitourinary Disorders
1. Urinary Retention
2. Overactive Bladder

V. Conclusion

This summary presentation aims to encompass the essential information concerning the pharmacology of autonomic nervous system drugs. The ANS plays a crucial role in the regulation of various physiological processes; thus, understanding and manipulating its function can be instrumental in managing a wide range of diseases. The classification, mechanisms of action, and therapeutic applications of sympathomimetic and parasympathomimetic drugs have been discussed in detail. Additionally, the clinical uses and potential adverse effects associated with the administration of these agents in various disorders have been emphasized. Overall, this presentation serves as a comprehensive overview of autonomic nervous system drugs, providing a solid foundation for further exploration of this important area of pharmacology.